(Applicant's Description) The Cancer Center at the University of California, San Diego was granted NCI designation as a Clinical Cancer Center in 1979. It is currently composed of 171 members drawn from 18 University departments and has a total peer-review funding of $43.5 million per annum(direct cost), of which $13.1 million per annum is awarded by the NCI. An additional $11.1 million per annum comes from non-peer reviewed sources. The Center conducts its collective research operations in over 119,000 sq. ft. of space, 47,000 sq. ft. of which are under the control of the Cancer Center Director. Cancer membership includes: One Nobel Laureate, five Members of the National Academy of Sciences, two Members of the National Institute for Environmental Health Sciences, one member of the Advisory Council of the NCI, and the President of the American Association of Cancer Research. This application proposes an updated structure of seven Research Programs which reflect its scientific strengths and evolving interes ts, namely Cancer Biology, Cancer Genetics, Cancer Pharmacology, Cancer Prevention and Control, Palliative Care, Translational Oncology and Viral Malignancy. It also consists of 10 shared resources, namely Animal Experimentation, Behavioral Assessment and Counseling, Biostatistics, Clinical Trials Office/Protocol Review, Digital Imaging, Flow Cytometry, Histology and Immunohistochemistry, Informatics, Molecular Pathology and Transgenic Mouse. Our shared resources and programmatic alignments are designed to facilitate the flow of discoveries from the basic and prevention research groups to the clinical scientists in the Center. These investigators are organized in organ- or research-specific focus groups to facilitate the practical application of new discoveries. It is also specifically structured to encourage the counter flow of clinical observations and phenomena so that collaborative investigation by all research disciplines is stimulated. Translational oncology embodies the ce ntral philosophy of UCSD Cancer Center, which places the highest priority and emphasis on converting the discoveries from high quality research into tangible improvements in prevention, diagnosis, treatment and amelioration of discomfort for the benefit of the community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023100-17
Application #
6172122
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
1978-04-01
Project End
2001-04-30
Budget Start
2000-05-26
Budget End
2001-04-30
Support Year
17
Fiscal Year
2000
Total Cost
$1,111,343
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Jiang, Qingfei; Jamieson, Catriona (2018) BET'ing on Dual JAK/BET Inhibition as a Therapeutic Strategy for Myeloproliferative Neoplasms. Cancer Cell 33:3-5
Ramirez, Oscar; Aristizabal, Paula; Zaidi, Alia et al. (2018) Implementing a Childhood Cancer Outcomes Surveillance System Within a Population-Based Cancer Registry. J Glob Oncol :1-11
Liu, Liang; Yang, Lin; Yan, Wei et al. (2018) Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis. Clin Cancer Res 24:2370-2382
Lwin, Thinzar M; Murakami, Takashi; Miyake, Kentaro et al. (2018) Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore. Ann Surg Oncol 25:1079-1085
Singh, Siddharth; Loomba, Rohit (2018) Role of two-dimensional shear wave elastography in the assessment of chronic liver diseases. Hepatology 67:13-15
Hartman, Sheri J; Nelson, Sandahl H; Myers, Emily et al. (2018) Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: The memory & motion study. Cancer 124:192-202
Hoffmann, Hanne M; Gong, Ping; Tamrazian, Anika et al. (2018) Transcriptional interaction between cFOS and the homeodomain-binding transcription factor VAX1 on the GnRH promoter controls Gnrh1 expression levels in a GnRH neuron maturation specific manner. Mol Cell Endocrinol 461:143-154
Liu, Xuxiang; Cao, Minghui; Palomares, Melanie et al. (2018) Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts. Breast Cancer Res 20:127
Huang, Justin K; Carlin, Daniel E; Yu, Michael Ku et al. (2018) Systematic Evaluation of Molecular Networks for Discovery of Disease Genes. Cell Syst 6:484-495.e5
Kalyanaraman, Hema; Schwaerzer, Gerburg; Ramdani, Ghania et al. (2018) Protein Kinase G Activation Reverses Oxidative Stress and Restores Osteoblast Function and Bone Formation in Male Mice With Type 1 Diabetes. Diabetes 67:607-623

Showing the most recent 10 out of 862 publications